Search results

Medscape: 'Long COVID and Returning to Work: A Hard and Frustrating Road' 'Around 16 million workers have been affected nationwide by long COVID.' '“Understanding how costly this disease is, we should be all-in when it comes to researching effective treatments,” said McComsey.’

Families USA: 'Armond Dai: Navigating Long COVID, Disability Hurdles and Medicaid Cuts' 'Armond Dai was building a promising career in architecture in Washington, DC when everything changed. After contracting COVID-19 twice, he developed a series of chronic illnesses that left him unable to...

'RECOVER-Treating Long COVID (TLC) 2nd Annual Workshop: Pathways to Treatments' 'Draft Agenda - Subject to Change' 'September 9-10, 2025 at The Bethesdan Hotel in Bethesda, Maryland' Based on the draft agenda, it seems that RECOVER-TLC has selected the following 4 agents to trial next for...

Santa Fe New Mexican: 'Long COVID symposium in Santa Fe aims to improve diagnoses, treatment’ 'Altmann said the symposium is about inviting international experts on long COVID together to “knock their heads together” in search of answers for patients.’ “There are so many bright people and so...

The Inquirer and Mirror: 'Researchers look to Nantucket for answers on chronic Lyme disease' 'Telford and his research team will be stationed at the 131 Pleasant Street Trailer on Friday, from 9 a.m. to 5 p.m., collecting blood samples and health surveys from volunteers. The effort is part of a...

Massachusetts General Hospital: 'Post-Infection Symptoms Explored: Deep Dive' 'In this Q&A, Dr. Komaroff shares what motivated this research and what it could mean for how we understand, diagnose, and treat these complex conditions.' Excerpts: "We think it is likely that these symptoms may be...

Sharing from Twitter #NotJustFatigue: "Big win in the Senate! After more than a year of advocating for federal research funding, Congress has officially recognized the ME/CFS Research Roadmap—and is now directing NIH to create a detailed implementation plan. This is a major step forward in...

Mass General: 'Drug for celiac disease shows promise in treating severe post-COVID syndrome in children’ 'A small, randomized clinical trial led by Mass General Brigham investigators found the oral drug larazotide—an experimental drug originally designed to treat celiac disease—was both safe...

Cell Reports Medicine: 'Causes of symptoms and symptom persistence in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome' By Anthony L. Komaroff & Robert Dantzer 'Many similar underlying biological abnormalities have been identified in both conditions including autoantibodies...

7/30/25, Institute for Systems Biology: 'Unraveling Long COVID: New Insights, Trials, and Hope for the Future' RECOVER Pacific Townhall Dr. Jason Goldman Dr. Katherine Tuttle Julie Wallick Lea Dahlke Ethan Pascual An in-depth town hall on the latest in long COVID research. This session...

From Jaime Seltzer on BlueSky: https://bsky.app/profile/exceedhergrasp1.bsky.social/post/3lv5ihe7wrk2i "Learned earlier this evening that the #MECFS Collaborative Research Center at Columbia's funding was restored... it's a huge relief to know that their work will move forward. Congrats to the...

7/25/25, NIH: 'The NIH RECOVER Program Announces Plan to Request Ancillary Studies’ Issued by National Heart, Lung, and Blood Institute (NHLBI) 'Ancillary studies will build on RECOVER’s robust infrastructure while addressing gaps in knowledge regarding the natural history, pathophysiological...

7/22/25, NIH: 'Mitochondria and health’ Excerpt: Viral Damage Infections may also affect how mitochondria function. Many researchers now think that mitochondrial damage from viruses holds clues to some medical conditions that have long vexed scientists. One such condition, called myalgic...

The Lancet: “Avindra Nath: in pursuit of pandemics” “His work has shifted understanding of both the underlying causes of neurological diseases and the unexpected impacts of viral infections..”...

'Save the Date for the Second Annual RECOVER-TLC Workshop' The second annual RECOVER-TLC Workshop is planned for Sept. 9-10, 2025. The workshop will again be hybrid — with in-person and virtual options. This year, we are making several changes based on feedback from the inaugural 2024 workshop...

Source NM: '‘It’s not over’: New Mexico doctor discusses the lasting effects of COVID-19' 'UNM promotes Long COVID researcher to distinguished professor' She led clinical trials for acute COVID treatments, including those that established the effectiveness of antiviral remdesivir and...

BMC: "Quality improvement of a community-engaged authorship system: lessons learned from the RECOVER initiative" "In conclusion, this QI project has provided valuable insights into the effectiveness of RECOVER’s Representative Authorship system."

6/30, A Chat with Uma: From Foster Care to Harvard Neuroscientist: "The Choice to Live, Maternal Psychedelics & Post-Viral Chronic Illnesses with Dr. Ya’el Courtney“ "Covid was a horrible thing..but it drew public attention and scientific attention to post-viral conditions that affect the...

7/2: 'RECOVER’s mid-year milestones: A look at 2025 progress' "During the first half of the year, RECOVER met enrollment goals for 1 of its clinical trials, launched new pathobiology studies, and continued seeking participants for additional clinical trials and its autopsy study." 'Both the...

Univ. of Utah: 'Research Groundbreakers: What’s Behind Long COVID? Dr. Yue Lu is on The Case' 'Dr. Lu, an Assistant Professor in the Department of Molecular Pharmaceutics at the University of Utah, and a member of the Experimental Therapeutics Program at the Huntsman Cancer Institute, is...